TCL1B (T cell leukemia protein 1B, SYN1, [p15]TML1)

Products_type

Antibody
Products_short_name

[TCL1B]
Products_name_syn

[Anti -TCL1B (T cell leukemia protein 1B, SYN1, [p15]TML1)]
Other_names

[T-cell leukemia/lymphoma protein 1B; T-cell leukemia/lymphoma protein 1B; T-cell leukemia/lymphoma protein 1B; oncogene TCL-1B; TCL1/ MTCP1-like 1; T-cell lymphoma/leukemia 1B; syncytiotrophoblast-specific protein; T-cell leukemia/lymphoma 1B; Oncogene TCL-1B; Oncogene TCL1B; SYN-1; Syncytiotrophoblast-specific protein; TCL1/MTCP1-like protein 1]
Other_gene_names

[TCL1B; TCL1B; TML1; SYN-1; TCL1; Oncogene TCL1B]
Clonality

Polyclonal
Reactivity

Human
Specificity

Recognizes human TCL1B. Species sequence homology: recombinant human TCL1A (5%).
Purity

Affinity Purified Purified by immunoaffinity chromatography.
Form

Supplied as a lyophilized powder in PBS, trehalose. Reconstitute with sterile PBS to 200ug/ml.
Storage_stability

Lyophilized powder may be stored at -20 degree C. Stable for 12 months at -20 degree C. Reconstitute with sterile PBS. Aliquot to avoid repeated freezing and thawing. Store at -20 degree C. Reconstituted product is stable for 12 months at -20 degree C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.
Tested_application

Immunohistochemistry (IHC)
Description

For cells, cell lines and tissues in culture till half confluency.

Gene target

TCL1B leukemia protein SYN1 [p15]TML1
Gene symbol

TCL1B, SYN1
Short name

TCL1B (T leukemia protein 1B, SYN1, [p15]TML1)
Host

Goat
Isotype

IgG
Alternative name

T-cellular leukemia/lymphoma 1B (T cellular leukemia protein 1B, SYN1, [p15]TML1)
Alternative to gene target

T-cell leukemia/lymphoma 1B, SYN-1 and TML1, TCL1B and IDBG-244466 and ENSG00000213231 and 9623, multiple, TCL1B and IDBG-634159 and ENSBTAG00000009653 and 100848382
Tissue

cell
Virus

leukemia

Name

Leukemia, Experimental
Concept

Scope note: Leukemia induced experimentally in animals by exposure to leukemogenic agents, such as VIRUSES; RADIATION; or by TRANSPLANTATION of leukemic tissues.
Tree numbers
- C04.557.337.372
- C04.619.531
- E05.598.500.496.500
Qualifiers

diagnosis, parasitology, immunology, microbiology, diagnostic imaging, physiopathology, rehabilitation, enzymology, etiology, mortality, epidemiology, blood, cerebrospinal fluid, chemically induced, congenital, diet therapy, drug therapy, therapy, psychology, urine, virology, history, classification, economics, embryology, genetics, nursing, radiotherapy, ethnology, prevention & control, pathology, metabolism, complications, surgery